07.02.2017
- US drugmaker Mylan is facing a probe from the Federal Trade Commission (FTC) as to whether it has violated antitrust laws in protecting its EpiPen from lower-priced competitors...
31.01.2017
- US company Barr Laboratories, a subsidiary of Israeli drugmaker Teva, has reached a $225 million settlement in an antitrust class action that accused Teva of keeping a generic...
